Showing results (41-50 of 112) with videos related to

Sort By:
Pageof 12
Plos One|August 30, 2018
Associations between obesity, smoking and lymph node status at breast cancer diagnosis in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening TrialAmelia Smith, Maeve Mullooly, Laura Murphy, et al.
Archives of Disease in Childhood|October 27, 2019
Accelerating diagnosis for childhood brain tumours: an analysis of the HeadSmart UK population dataDhurgshaarna Shanmugavadivel, Jo-Fen Liu, Laura Murphy, et al.
Plos One|November 2, 2017
Human-centred design in global health: A scoping review of applications and contextsAlessandra N Bazzano, Jane Martin, Elaine Hicks, et al.
BMJ Open Quality|October 21, 2025
Reducing door-to-ECG time in the emergency department: a quality improvement reportShantanu Srivatsa, Zeliha Ozen, Taylor English, et al.
International Journal of Clinical Pharmacy|September 30, 2020
Exploring the use of extended release opioids at shortened dosing intervals in people with chronic pain and high risk medication or substance useLaura Murphy, Bruna Brands, Daniel Grant, et al.
Pain Reports|December 6, 2021
Ten years of interfaculty pain curriculum at the University of Toronto: impact on student learningIacopo Cioffi, Craig M Dale, Laura Murphy, et al.
Pain Reports|September 21, 2022
Ten-year mixed-method evaluation of prelicensure health professional student self-reported learning in an interfaculty pain curriculumCraig M Dale, Iacopo Cioffi, Laura Murphy, et al.
Integrated Pharmacy Research & Practice|May 7, 2021
The Role of the Pharmacist in the Care of Patients with Chronic PainLaura Murphy, Karen Ng, Pearl Isaac, et al.
Issues in Mental Health Nursing|September 27, 2014
Women's functioning following an intervention for partner violence: new knowledge for clinical practice from a 7-year studyAnne Floyd Koci, Judith McFarlane, Sandra Cesario, et al.
Bioorganic Chemistry|May 4, 2024
2,2- dimethylbenzopyran derivatives containing pyridone structural fragments as selective dual-targeting inhibitors of HIF-1α and EZH2 for the treatment of lung cancerHuashen Xu, Jie Zhang, Junning Zhuang, et al.
Pageof 12